VNDA - Vanda Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VNDA is currently covered by 4 analysts with an average price target of $12.68. This is a potential upside of $5.68 (81.14%) from yesterday's end of day stock price of $7.

Vanda Pharmaceuticals's activity chart (see below) currently has 67 price targets and 68 ratings on display. The stock rating distribution of VNDA is 90% BUY and 10% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 78.18% with an average time for these price targets to be met of 400.64 days.

Highest price target for VNDA is $24, Lowest price target is $7.5, average price target is $15.75.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 23-Feb-2026. First documented stock forecast 20-Jun-2013.

Currently out of the existing stock ratings of VNDA, 9 are a BUY (90%), 1 are a HOLD (10%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 31-Oct-2024

$24

$17 (242.86%)

$22

1 months 12 days ago
(23-Feb-2026)

0/14 (0%)

$15.85 (194.48%)

Hold Since 26-Feb-2022

$7.5

$0.5 (7.14%)

3 months 4 days ago
(31-Dec-2025)

4/5 (80%)

$-1.32 (-14.97%)

30

Buy Since 06-Feb-2019

$13

$6 (85.71%)

$13

1 years 1 months 21 days ago
(14-Feb-2025)

4/8 (50%)

$8.58 (194.12%)

354

Hold Since 11-Feb-2021

$18

$11 (157.14%)

$14

5 years 1 months 24 days ago
(11-Feb-2021)

9/9 (100%)

$-0.67 (-3.59%)

210

Sell Since 16-Mar-2020

$7

$21

6 years 19 days ago
(16-Mar-2020)

4/4 (100%)

$-1.1 (-13.58%)

277

Show more analysts

Please expand the browser size to see the chart

What is VNDA (Vanda Pharmaceuticals) average time for price targets to be met?

On average it took 400.64 days on average for the stock forecasts to be realized with a an average price target met ratio 78.18

Which analyst has the current highest performing score on VNDA (Vanda Pharmaceuticals) with a proven track record?

DEREK ARCHILA

Which analyst has the most public recommendations on VNDA (Vanda Pharmaceuticals)?

Derek Archila works at WELLS FARGO and has 2 price targets and 3 ratings on VNDA

Which analyst is the currently most bullish on VNDA (Vanda Pharmaceuticals)?

Jason Butler with highest potential upside - $18

Which analyst is the currently most reserved on VNDA (Vanda Pharmaceuticals)?

Derek Archila with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?